Levomenthol

ๅทฆๆ—‹่–„่ท้†‡

Report date: 2026/05/02 20:00:18

Base Information

Drug NameLevomenthol
Drug Alias NameLevomentholumL-่–„่ท้†‡(-)-Mentholๅทฆๆ—‹่–„่ท่„‘่–„่ท้†‡ +[8]ย 
ClassificationSmall molecules
Mechanisms of ActionKappa opioid receptor antagonistsTransient receptor potential cation channel subfamily M member 8 agonists
TargetsKappa opioid receptorTransient receptor potential cation channel subfamily M member 8
Therapy Area/IndicationsColonic PolypsPulmonary Disease, Chronic ObstructiveLung Diseases, Interstitial +[6]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenJapan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospitals Cleveland Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesBlekinge Institute Of TechnologyLund University
Inactive CompaniesNihon Pharmaceutical Co LtdUniversity Hospitals Cleveland Medical Center
Active IndicationsPulmonary Disease, Chronic ObstructiveLung Diseases, InterstitialAsthma
Inactive IndicationsColonic PolypsIntestinal DiseasesColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG